SpliceBio has raised 50 million euros ($57 million) from a starry syndicate to tackle one of the biggest barriers in gene therapy. Armed with the series A funds, the Barcelona-based biotech will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results